Holmes Biopharma, Inc. (LMB) Reports Q3 Loss of $0.12/Share
Get Alerts LMB Hot Sheet
Join SI Premium – FREE
Holmes Biopharma, Inc. (NASDAQ: LMB) reported Q3 EPS of ($0.12), versus $0.27 reported last year. Revenue for the quarter came in at $121.3 million, versus $91.89 million reported last year.
GUIDANCE:
Holmes Biopharma, Inc. sees Q4 2017 revenue of $460-470 million.
For earnings history and earnings-related data on Holmes Biopharma, Inc. (LMB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Rexford Industrial Realty (REXR) Reports In-Line Q1 EPS, provides guidance
- Liberty Oilfield Services (LBRT) Misses Q1 EPS by 6c, provides outlook
- Kinder Morgan (KMI) Misses Q1 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!